Quick Answer
Ingevity Corp reported Cash and Equivalents of $78.10 million for fiscal year 2025.
Ingevity Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $78.10M | +14.9% |
| 2024 | $68.00M | -29.1% |
| 2023 | $95.90M | +25.0% |
| 2022 | $76.70M | -72.1% |
| 2021 | $275.40M | +6.9% |
| 2020 | $257.70M | +356.1% |
| 2019 | $56.50M | -27.1% |
| 2018 | $77.50M | -11.8% |
| 2017 | $87.90M | +188.2% |
| 2016 | $30.50M | -4.7% |
| 2015 | $32.00M | +60.8% |
| 2014 | $19.90M | +73.0% |
| 2013 | $11.50M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $83.40M | -38.5% | +8.5% |
| June 30, 2025 | $76.90M | -28.4% | +7.6% |
| March 31, 2025 | $71.50M | -19.2% | +5.1% |
| December 31, 2024 | $68.00M | -29.1% | -49.8% |
| September 30, 2024 | $135.50M | +60.4% | +26.2% |
| June 30, 2024 | $107.40M | +57.9% | +21.4% |
| March 31, 2024 | $88.50M | +13.6% | -7.7% |
| December 31, 2023 | $95.90M | +25.0% | +13.5% |
- Ingevity Corp showed an increase of +14.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2013–2025 period, Ingevity Corp’s cash and equivalents has grown by 579.1% (from $11.50 million to $78.10 million).
- The most recent figure is from Ingevity Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: